First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: A quality of life directed phase II randomized trial of Gruppo Oncologico Italia MeridionaleVittorio Gebbia, Giuseppe Colucci, Francesco Ferraù et al.|Lung Cancer|2009Cited by 18
A Multicenter Phase Ii Trial of Nab-Paclitaxel in Combination with Capecitabine in Patients (Pts) with Her-2 Negative and Triple Negative Advanced Breast Cancer (Abc): an Interim AnalysisMariangela Ciccarese, Saverio Cinieri, Laura Orlando et al.|Annals of Oncology|2014Cited by 0
First-line cisplatin (P) with docetaxel (TXT) or vinorelbine (VNR) in patients with advanced non-small-cell lung cancer: A phase II randomized trial of Gruppo Oncologico Italia MeridionaleVittorio Gebbia, Giuseppe Colucci, Vito Lorusso et al.|European Journal of Cancer Supplements|2008Cited by 0
First-line cisplatin (P) with docetaxel (TXT) or vinorelbine (VNR) in patients with advanced non-small cell lung cancer: A randomized phase II trial of the Gruppo Oncologico Italia MeridionaleVittorio Gebbia, Saverio Cinieri, Domenico Galetta et al.|Journal of Clinical Oncology|2009Cited by 0
A multicenter phase II trial of nab‐paclitaxel and capecitabine in HER‐2 negative and triple‐ negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?Mariangela Ciccarese, Laura Orlando, Palma Fedele et al.|The Breast Journal|2020Cited by 0